文献速递肺外科心外重症与机械循环支持

肺移植术中体外膜氧合支持的长期结局

Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation.
PubMed 文献 · J Heart Lung Transplant · 2020-04-29

该单中心回顾性研究分析了2010年1月至2019年6月间接受孤立肺移植的患者,其中27%(311/1161)术中使用了ECMO。ECMO组术前风险更高且术后早期病程更复杂,住院死亡率更高(10.9% vs 2.3%,p<0.001),总体移植物生存更差(p=0.0025);但校正至出院存活者后,两组5年生存率(71% vs 72%,p=0.56)及慢性肺移植物功能障碍、排斥反应等长期结局无差异。

要点

  • 肺移植术中ECMO支持患者术前风险更高、术后早期并发症更多。
  • ECMO组住院死亡率10.9%,显著高于无支持组的2.3%。
  • 出院存活者中,ECMO组与无支持组5年生存率无显著差异。

核心结论

  • 肺移植术中ECMO支持者围术期及术后早期病程更复杂,但出院存活者长期并发症和结局与无支持者无差异。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010年1月至2019年6月间接受孤立肺移植的患者,排除使用CPB者,随访至2019年9月1日(中位3.34年)。

主要发现

  • 1161例肺移植受者中311例(27%)术中接受ECMO,24例(2%)进一步需要CPB,余826例(71%)未需术中心肺支持。
  • ECMO组住院死亡率10.9%,无ECMO组2.3%(p<0.001)。
  • ECMO组总体移植物生存更差(p=0.0025)。
  • 出院存活者中,ECMO组与无ECMO组5年生存率分别为71%和72%(p=0.56)。
  • 两组慢性肺移植物功能障碍、活检证实的细胞性排斥反应及需脉冲激素治疗的比例均无差异(p=0.99、p=0.78、p=0.93)。

临床怎么用

  • 术中ECMO支持患者术后早期需更严密监护以降低住院死亡风险。
  • 对度过围术期出院的ECMO患者,长期随访策略可与无支持者类似。

局限性

  • 单中心回顾性研究,ECMO组术前风险更高,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Over the past decade, extracorporeal membrane oxygenation (ECMO) has replaced cardiopulmonary bypass (CPB) for cardiopulmonary support during lung transplantation at our institution. In this study, we present our experience using intraoperative ECMO in isolated lung transplantation and evaluate its impact on long-term graft function and survival. METHODS: All patients undergoing isolated lung transplantation with or without ECMO support between January 2010 and June 2019 were evaluated. Patients transplanted using CPB were excluded. Peri-operative and follow-up results from our database and patient charts were analyzed. Follow-up continued until September 1, 2019 (median, 3.34 years). RESULTS: In total, 311 of 1,161 lung transplant recipients (27%) received intraoperative ECMO, with 24 (2%) patients further requiring CPB. None of the remaining 826 (71%) patients required intraoperative cardiopulmonary support. ECMO patients exhibited higher pre-transplant surgical risk profiles and endured more complicated early post-operative courses than those without ECMO (in-hospital mortality, 10.9% vs 2.3%; p < 0.001). Inevitably, this resulted in poorer overall graft survival among ECMO recipients (p = 0.0025). However, correcting for patients surviving to hospital discharge, no difference in survival between groups was observed (5-year survival, 71% vs 72%; p = 0.56). Similarly, freedom from chronic lung allograft dysfunction, biopsy-confirmed cellular rejection, or need for pulsed-steroid therapy did not differ between the groups (p = 0.99, p = 0.78, and p = 0.93, respectively). CONCLUSIONS: Compared with patients not requiring cardiopulmonary support, ECMO recipients endured a more complicated peri-operative and early post-operative course. However, among those surviving to hospital discharge, no differences in long-term complications or outcomes were observed.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Ius F, Aburahma K, Boethig D, et al. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation. J Heart Lung Transplant. 2020. PMID: 32444157. doi:10.1016/j.healun.2020.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。